# CPG 230.120- Human Blood and Blood Products as Drugs - FDA Guidance Document

Source: https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-230120-human-blood-and-blood-products-as-drugs/6ddcee95-2636-4d4a-91f0-d7f328e8f0ae

> FDA guidance document: CPG 230.120- Human Blood and Blood Products as Drugs. Issue date: September 30, 1980. Get complete insights and analysis.

---

## Details

- Title: CPG 230.120- Human Blood and Blood Products as Drugs
- Communication Type: Compliance Policy Guide (CPG)
- Product Type: Biologics, Drugs
- Office Name: Office of Regulatory Affairs
- Issue Date: 1980-09-30

## Related Documents

- [CPG Sec. 420.200 Compendium Revisions and Deletions](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-420200-compendium-revisions-and-deletions/b866bcfb-f0db-415c-a295-177a10dcaef7)
- [CPG Sec. 400.800 Collection and Charitable Distribution of Drugs](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-400800-collection-and-charitable-distribution-of-drugs/6e883362-56eb-4f2d-a1e9-cf95fcc82aac)
- [CPG Sec. 400.335 Fructose-Containing Drugs](https://www.keypedia.com/guidances/compliance-policy-guide-cpg/cpg-sec-400335-fructose-containing-drugs/b2d83802-4ef8-4e27-898d-5cf354f406ab)